| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Coo/ CFO | Chief Financial Officer
2 companies
Giraudo Bryan is a Coo/ CFO at GOSS, with reported holdings spanning 2 companies. Recent filings cover 12 purchases and 7 sales. Those positions are worth an estimated $1.3M at current prices.
Our model assigns Giraudo Bryan a strong insider score of 73/100, based on 8 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +20.6%.
Giraudo Bryan's largest disclosed position is in PTGX as Director, worth about $1.3M. The recent filings there lean toward selling, a net 41,130 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 | PTGX Protagonist Therapeutics, Inc. | Director | Sale+OE | 59,130 | $100.10 | $5,918,880.00 | -82.3% | +47.1% | - | |
| Jun 18, 2024 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Buy | 100,000 | $0.59 | $59,110.00 | +26.3% | +67.8% | +137.8% | |
| Mar 27, 2024 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Sell | 6,430 | $1.16 | $7,430.51 | -6.5% | -13.7% | -0.9% | |
| Nov 13, 2023 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Buy | 200,000 | $0.56 | $112,880.00 | +111.1% | +39.7% | +34.6% | |
| Apr 4, 2023 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Buy | 55,000 | $1.02 | $56,094.50 | +77.5% | +30.0% | +9.4% | |
| Mar 20, 2023 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Buy | 50,000 | $0.97 | $48,435.00 | +238.2% | +8.7% | +14.9% | |
| Jul 15, 2022 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Buy | 13,869 | $7.21 | $99,995.49 | +194.8% | +9.9% | -86.6% | |
| Mar 23, 2022 | GOSS Gossamer Bio, Inc. | Coo/ CFO | Sell | 10,722 | $8.92 | $95,586.63 | -9.8% | -20.1% | -87.8% | |
| Mar 23, 2021 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Sell | 5,490 | $9.48 | $52,045.75 | -4.8% | -7.0% | -3.4% | |
| Oct 14, 2020 | GOSS Gossamer Bio, Inc. | Chief Financial Officer | Buy | 3,000 | $10.01 | $30,036.00 | +72.8% | - | - |